Raphael Pharmaceutical (RAPH) Current Assets (2020 - 2025)

Raphael Pharmaceutical has disclosed Current Assets across 6 years of filings, most recently posting $51000.0 for Q4 2025.

• Current Assets for Q4 2025 came in at $51000.0, up 104.0% year-over-year; the trailing twelve-month figure through Dec 2025 was $51000.0 (up 104.0% YoY), and the FY2025 annual result was $51000.0, up 104.0% from the prior year.
• Current Assets came in at $51000.0 for Q4 2025 at Raphael Pharmaceutical, up from $5000.0 in the prior quarter.
• In the past five years, Current Assets ranged from a high of $422000.0 in Q4 2021 to a low of $5000.0 in Q3 2025.
• The 5-year median for Current Assets is $122500.0 (2022), against an average of $163388.9.
• Across the five-year window, Current Assets soared 237.82% in 2023 and slumped 89.8% in 2025, its largest moves.
• Raphael Pharmaceutical's Current Assets stood at $422000.0 in 2021, then retreated by 21.56% to $331000.0 in 2022, then slipped by 28.4% to $237000.0 in 2023, then sank by 89.45% to $25000.0 in 2024, then jumped by 104.0% to $51000.0 in 2025.
• The last three Current Assets figures came in at $51000.0 (Q4 2025), $5000.0 (Q3 2025), and $28000.0 (Q2 2025), per Business Quant data.